Manuscripts

Sensitivity and Specificity of the NETest: A Validation Study
June 7, 2023Sensitivity and Specificity of the NETest: A Validation Study

NETest: A Systematic Review Focusing on the Prognostic and Predictive Role
June 7, 2023NETest: A Systematic Review Focusing on the Prognostic and Predictive Role

A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
June 7, 2023A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection
June 7, 2023Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection

PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest
June 7, 2023PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
May 4, 2023The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

Clinical Utility of Blood-based multi-transcriptome diagnostic for GI NETS
May 4, 2023Clinical Utility of Blood-based multi-transcriptome diagnostic for GI NETS

PRRT Neuroendocrine Tumor Response monitored using Circulating Transcript Analysis: The NETest
May 4, 2023PRRT Neuroendocrine Tumor Response monitored using Circulating Transcript Analysis: The NETest

Neuroendocrine Neoplasia Diagnosis: mRNA biomarker NETest exhibits 3-5 times greater accuracy than Chromogranin A
May 4, 2023Neuroendocrine Neoplasia Diagnosis: mRNA biomarker NETest exhibits 3-5 times greater accuracy than Chromogranin A

NETest demonstrates surgical and clinical utility
May 4, 2023NETest demonstrates surgical and clinical utility

Therapy: The role of liquid biopsies to manage and predict PRRT for NETs
April 12, 2023Therapy: The role of liquid biopsies to manage and predict PRRT for NETs

PRRT genomic signature in blood for prediction of 177 Lu-octreotate efficacy
April 12, 2023PRRT genomic signature in blood for prediction of 177 Lu-octreotate efficacy

Blood Neuroendocrine Gene Transcript Measurement Utility in BPNET Diagnosis, Surgical Resection and Disease Progression Evaluation
April 12, 2023Blood Neuroendocrine Gene Transcript Measurement Utility in BPNET Diagnosis, Surgical Resection and Disease Progression Evaluation

Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy
April 12, 2023Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy

NET blood transcript analysis defines the crossing of the clinical Rubicon: when stable disease becomes progressive
April 12, 2023NET blood transcript analysis defines the crossing of the clinical Rubicon: when stable disease becomes progressive

Circulating neuroendocrine gene transcript analysis utility in well-differentiated Paragangliomas and Pheochromocytomas
April 12, 2023Circulating neuroendocrine gene transcript analysis utility in well-differentiated Paragangliomas and Pheochromocytomas

Assessment of NETest Clinical utility in a US Registry-based study
April 12, 2023Assessment of NETest Clinical utility in a US Registry-based study

Multianalyte PCR blood test outperforms single analyte ELISAs for neuroendocrine tumor detection
April 12, 2023Multianalyte PCR blood test outperforms single analyte ELISAs for neuroendocrine tumor detection

A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by PPIs
April 12, 2023A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by PPIs

The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract
April 12, 2023The Clinical Utility of a Novel Blood-Based Multi-Transcriptome Assay for the Diagnosis of Neuroendocrine Tumors of the Gastrointestinal Tract

The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas
April 12, 2023The clinical utility of circulating neuroendocrine gene transcript analysis in well-differentiated paragangliomas and pheochromocytomas

A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
April 12, 2023A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis

The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
April 12, 2023The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood

Gut neuroendocrine tumor blood qPCR fingerprint assay: characteristics and reproducibility
April 12, 2023Gut neuroendocrine tumor blood qPCR fingerprint assay: characteristics and reproducibility

Blood and Tissue NET Gene Cluster Analysis correlate, define Hallmarks and Predict Disease Status
April 12, 2023Blood and Tissue NET Gene Cluster Analysis correlate, define Hallmarks and Predict Disease Status

The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors
April 12, 2023The Clinical Utility of Multigene Blood Analysis in the Diagnosis and Management of Neuroendocrine Tumors

Senator Murphy names Wren Connecticut Innovator of the Month
April 12, 2023Senator Murphy names Wren Connecticut Innovator of the Month

Liquid Biopsy Blood Biomarker Possible Predictor of Tumor Recurrence, Cost Savings
April 12, 2023Liquid Biopsy Blood Biomarker Possible Predictor of Tumor Recurrence, Cost Savings
